Literature DB >> 2145198

Isolation and characterization of the gene encoding the muscle-specific isozyme of human phosphoglycerate mutase.

J Castella-Escola1, D M Ojcius, P LeBoulch, V Joulin, Y Blouquit, M C Garel, C Valentin, R Rosa, F Climent-Romeo, M Cohen-Solal.   

Abstract

The human muscle-specific phosphoglycerate mutase encoding gene (PGAM-M) has been cloned from a genomic cosmid library and sequenced. The sequence corresponding to the coding region was evaluated and revised by sequencing of the protein itself, fully confirming our results. The amino acid sequence of the M isozyme presented a 80.6% homology with the B isozyme (non-muscle-specific isozyme), a value higher than previously reported. The PGAM-M gene is composed of three exons, which consist of 454, 180 and 202 bp, respectively, and are separated by two introns of 103 bp and approx. 5.6 kb, respectively. Comparison of the structure of the human PGAM-M gene with that coding for human bisphosphoglycerate mutase, an erythroid-specific enzyme belonging to the same multifunctional enzyme family, revealed that the location of the second intron is similar in each gene and corresponds to a tertiary subdomain in the spatial structure of the protein. The transcription start point (tsp) in the PGAM-M gene was identified by both primer extension and S1 nuclease-protection experiments. A TATA-box-like element was observed 29 bp upstream from the tsp; the sequence ATTGG, inverse/complementary to CCAAT-box, was found 40 bp upstream from the supposed TATA box. No muscle-specific consensus sequences could be detected in the 5'-untranslated region. Only one polyadenylation AATAAA signal was observed in the short 3'-untranslated region (43 bp long). Finally, only one copy of this gene is present in the human genome instead of the several copies found for the PGAM-B gene, suggesting the possible evolutionary origin of the muscle subunit in a modified copy of the PGAM-B gene.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2145198     DOI: 10.1016/0378-1119(90)90092-6

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  8 in total

1.  Nuclear location of phosphoglycerate mutase BB isozyme in rat tissues.

Authors:  G Egea; J M Ureña; X Graña; J Marsal; J Carreras; F Climent
Journal:  Histochemistry       Date:  1992

2.  New nucleotide sequence data on the EMBL File Server.

Authors: 
Journal:  Nucleic Acids Res       Date:  1991-01-11       Impact factor: 16.971

3.  Modelling the 2-kinase domain of 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase on adenylate kinase.

Authors:  L Bertrand; D Vertommen; E Depiereux; L Hue; M H Rider; E Feytmans
Journal:  Biochem J       Date:  1997-02-01       Impact factor: 3.857

4.  Higher-plant cofactor-independent phosphoglyceromutase: purification, molecular characterization and expression.

Authors:  Y Huang; S D Blakeley; S M McAleese; L A Fothergill-Gilmore; D T Dennis
Journal:  Plant Mol Biol       Date:  1993-12       Impact factor: 4.076

5.  Structure, expression and duplication of genes which encode phosphoglyceromutase of Drosophila melanogaster.

Authors:  P D Currie; D T Sullivan
Journal:  Genetics       Date:  1994-10       Impact factor: 4.562

6.  The molecular genetic basis of muscle phosphoglycerate mutase (PGAM) deficiency.

Authors:  S Tsujino; S Shanske; S Sakoda; G Fenichel; S DiMauro
Journal:  Am J Hum Genet       Date:  1993-03       Impact factor: 11.025

7.  Muscle phosphoglycerate mutase (PGAM) deficiency in the first Caucasian patient: biochemistry, muscle culture and 31P-MR spectroscopy.

Authors:  G Vita; A Toscano; N Bresolin; G Meola; F Fortunato; A Baradello; B Barbiroli; C Frassineti; P Zaniol; C Messina
Journal:  J Neurol       Date:  1994-03       Impact factor: 4.849

8.  Gene Expressions for Signal Transduction under Acidic Conditions.

Authors:  Toshihiko Fukamachi; Syunsuke Ikeda; Xin Wang; Hiromi Saito; Masatoshi Tagawa; Hiroshi Kobayashi
Journal:  Genes (Basel)       Date:  2013-03-08       Impact factor: 4.096

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.